Detalles de la búsqueda
1.
Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG).
Breast Cancer Res Treat
; 171(1): 11-20, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29725889
2.
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.
Lancet Oncol
; 14(11): 1121-1128, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24007746
3.
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
Clin Breast Cancer
; 21(1): 80-91.e7, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33183970
4.
A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer.
Clin Breast Cancer
; 20(3): e251-e260, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32139271
5.
Comutation of PIK3CA and TP53 in Residual Disease After Preoperative Anti-HER2 Therapy in ERBB2 (HER2)-Amplified Early Breast Cancer.
JCO Precis Oncol
; 3: 1-26, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35100698
6.
The effect of tamoxifen or exemestane on bone mineral density during the first 2 years of adjuvant treatment of postmenopausal women with early breast cancer.
Clin Breast Cancer
; 8(6): 527-32, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19073509
7.
Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast Cancer.
Clin Breast Cancer
; 18(1): e89-e95, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28779904
8.
Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancer.
Cancer Med
; 7(6): 2288-2298, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29582557
9.
Phase II trial of 10-EDAM in the treatment of metastatic breast cancer.
Cancer Chemother Pharmacol
; 60(1): 61-7, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17009032
10.
Incidence and Predictive Factors for Recovery of Ovarian Function in Amenorrheic Women in Their 40s Treated With Letrozole.
J Clin Oncol
; 34(14): 1594-600, 2016 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26884554
11.
Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.
Clin Breast Cancer
; 5(6): 439-46, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15748464
12.
Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine.
Clin Cancer Res
; 21(19): 4305-11, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26041745
13.
Bone pain associated with once-per-cycle pegfilgrastim is similar to daily filgrastim in patients with breast cancer.
Clin Breast Cancer
; 3(6): 391-8, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12636878
14.
Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling.
BMC Res Notes
; 6: 507, 2013 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24304724
15.
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
J Clin Oncol
; 27(8): 1177-83, 2009 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19204201
16.
Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudy.
J Clin Oncol
; 25(30): 4765-71, 2007 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-17947724
17.
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
J Clin Oncol
; 24(34): 5381-7, 2006 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17135639
18.
Pharmacogenomics of tamoxifen in a nutshell-and who broke the nutcracker?
J Oncol Pract
; 1(4): 155-9, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20871698
Resultados
1 -
18
de 18
1
Próxima >
>>